The Expression Patterns of Human Cancer-Testis Genes Are Induced through Epigenetic Drugs in Colon Cancer Cells

The Expression Patterns of Human Cancer-Testis Genes Are Induced through Epigenetic Drugs in Colon Cancer Cells

Background: The expression of human germline genes is restricted to the germ cells of the gonads, which produce sperm and eggs. The germline genes involved in testis development and potentially activated in cancer cells are known as cancer-testis (CT) genes. These genes are potential therapeutic tar...

Full description

Bibliographic Details
Main Authors:	Mikhlid H. Almutairi, Turki M. Alrubie, Bader O. Almutairi, Abdullah M. Alamri, Abdulwahed F. Alrefaei, Maha M. Arafah, Mohammad Alanazi, Abdelhabib Semlali
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Pharmaceuticals
Subjects:	cancer-testis (CT) gene DNA methyl-transferase inhibitor (DNMTi) histone deacetylase inhibitor (HDACi) immunotherapy colon cancer
Online Access:	https://www.mdpi.com/1424-8247/15/11/1319

Similar Items

Cancer-Testis Gene Biomarkers Discovered in Colon Cancer Patients
by: Mikhlid H. Almutairi, et al.
Published: (2022-05-01)

Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
by: Joanna Szczepanek, et al.
Published: (2023-04-01)

Higher Expression Levels of <i>SSX1</i> and <i>SSX2</i> in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation
by: Turki M. Alrubie, et al.
Published: (2023-05-01)

Influence of histone deacetylase inhibitors and DNA-methyltransferase inhibitors on the NK cell-mediated lysis of pediatric B-lineage leukemia.
by: Matthias Manuel Pfeiffer, et al.
Published: (2013-04-01)

Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas
by: Alain Chebly, et al.
Published: (2022-05-01)

Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer
by: Siddhartha Das Pramanik, et al.
Published: (2022-08-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
by: Dineo eKhabele
Published: (2014-05-01)

Identification and characterization of testis-specific gene expressions in mouse tissues
by: Turki M. Alrubie, et al.
Published: (2023-11-01)

Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
by: Nikolaos Garmpis, et al.
Published: (2021-03-01)

Expression of Adenoviral E1A in Transformed Cells as an Additional Factor of HDACi-Dependent FoxO Regulation
by: Alisa Morshneva, et al.
Published: (2019-12-01)

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
by: Lourdes Hontecillas-Prieto, et al.
Published: (2020-09-01)

HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models
by: María Del Carmen Rodríguez Rodríguez, et al.
Published: (2022-05-01)

Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
by: Bin Tu, et al.
Published: (2020-06-01)

Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy
by: Maria Mrakovcic, et al.
Published: (2019-12-01)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
by: Saikat Dewanjee, et al.
Published: (2021-05-01)

Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
by: Mohammed I. Y. Elmallah, et al.
Published: (2019-06-01)

HDAC Inhibitor Sodium Butyrate Attenuates the DNA Repair in Transformed but Not in Normal Fibroblasts
by: Olga O. Gnedina, et al.
Published: (2022-03-01)

HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines
by: Tobias S. Iveland, et al.
Published: (2020-04-01)

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma
by: Patrick B. Johnston, et al.
Published: (2021-02-01)

Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy
by: Fengkun Lu, et al.
Published: (2021-01-01)

HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
by: Jie Wang, et al.
Published: (2022-12-01)

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
by: Anton Frühauf, et al.
Published: (2021-08-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Oncolytic Virotherapy: The Cancer Cell Side
by: Marcelo Ehrlich, et al.
Published: (2021-02-01)

Molecular mechanistic pathways underlying the anticancer therapeutic efficiency of romidepsin
by: Nasreddine El Omari, et al.
Published: (2023-08-01)

A possible link to uracil DNA glycosylase in the synergistic action of HDAC inhibitors and thymidylate synthase inhibitors
by: Meredith S. Showler, et al.
Published: (2020-10-01)

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by: Duong Tien Anh, et al.
Published: (2023-02-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Nuclear protein of the testis midline carcinoma masquerading as a primary mediastinal seminoma
by: Maria S. Sayapina, et al.
Published: (2016-06-01)

CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models
by: Roberta Antonelli, et al.
Published: (2020-07-01)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
by: Long Xu, et al.
Published: (2023-10-01)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
by: Amandine Badie, et al.
Published: (2022-11-01)

Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review
by: Yingjun Zhang, et al.
Published: (2024-02-01)

Synergistic Effect of Simultaneous versus Sequential Combined Treatment of Histone Deacetylase Inhibitor Valproic Acid with Etoposide on Melanoma Cells
by: Yueh-Ming Shyu, et al.
Published: (2021-09-01)

Association between tobacco substance usage and a missense mutation in the tumor suppressor gene P53 in the Saudi Arabian population.
by: Mikhlid H Almutairi, et al.
Published: (2021-01-01)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
by: Mie K. Jakobsen, et al.
Published: (2020-09-01)

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
by: Robert Jenke, et al.
Published: (2021-02-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
by: Iason Psilopatis, et al.
Published: (2023-04-01)

Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
by: Silvia Consalvi, et al.
Published: (2013-03-01)